SINGULAR GENOMICS SYSTEMS
(NASDAQ: OMIC)

Singular Genomics Systems, Inc. engages in the development and commercialization of proprietary sequencing solutions. It develops two integrated solutions: G4 Instrument and PX Instrument. The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. The PX Instrument combines single cell and spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA.

13.320

+0.320 (+2.46%)
Range 12.550 - 14.370   (14.50%)
Open 12.550
Previous Close 13.000
Bid Price 1.010
Bid Volume 10
Ask Price -
Ask Volume 22
Volume 57,274
Value -
Remark
Delayed prices. Updated at 01 Nov 2024 04:00.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis